Original paper
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Abstract
Background
Hyperlipidemia, insulin resistance, and oxidative stress can heavily contribute to the initiation and progression of nonalcoholic fatty liver disease (NAFLD). Currently, there is no established treatment for this disease. Recently, several studies have shown that ezetimibe (EZ), a lipid-lowering drug, attenuates liver steatosis in an experimental NAFLD model. This study was designed to assess the efficacy of long-term EZ monotherapy...
Paper Details
Title
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Published Date
Jul 24, 2010
Journal
Volume
46
Issue
1
Pages
101 - 107
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History